SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline

BACKGROUND: Barely 10-20% of patients with metastatic colorectal cancer (mCRC) receive a clinical benefit from the use of anti-EGFR monoclonal antibodies (mAbs). We hypothesized that this could depends on their efficiency to reduce Store Operated Calcium Entry (SOCE) that are known to enhance cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Guéguinou, Maxime, Harnois, Thomas, Crottes, David, Uguen, Arnaud, Deliot, Nadine, Gambade, Audrey, Chantôme, Aurélie, Haelters, Jean Pierre, Jaffrès, Paul Alain, Jourdan, Marie Lise, Weber, Günther, Soriani, Olivier, Bougnoux, Philippe, Mignen, Olivier, Bourmeyster, Nicolas, Constantin, Bruno, Lecomte, Thierry, Vandier, Christophe, Potier-Cartereau, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094991/
https://www.ncbi.nlm.nih.gov/pubmed/27102434
http://dx.doi.org/10.18632/oncotarget.8786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094991/
https://www.ncbi.nlm.nih.gov/pubmed/27102434
http://dx.doi.org/10.18632/oncotarget.8786

Ejemplares similares